These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32181937)

  • 21. Improvement in cognitive impairment following the successful treatment of endogenous Cushing's syndrome-a case report and literature review.
    Brzozowska MM; Kepreotis S; Tsang F; Fuentes-Patarroyo SX
    BMC Endocr Disord; 2019 Jun; 19(1):68. PubMed ID: 31253144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging.
    Michaud K; Forget H; Cohen H
    Brain Cogn; 2009 Oct; 71(1):1-8. PubMed ID: 19428166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of cure in Cushing's syndrome: lessons from long-term follow-up.
    Barahona MJ; Resmini E; Sucunza N; Webb SM
    Front Horm Res; 2010; 38():152-157. PubMed ID: 20616506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of functional remission in Cushing's syndrome.
    Vermalle M; Alessandrini M; Graillon T; Paladino NC; Baumstarck K; Sebag F; Dufour H; Brue T; Castinetti F
    Endocrine; 2018 Sep; 61(3):518-525. PubMed ID: 30019306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease.
    Sonino N; Fava GA; Belluardo P; Girelli ME; Boscaro M
    Horm Res; 1993; 39(5-6):202-6. PubMed ID: 8314204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased prefrontal functional brain response during memory testing in women with Cushing's syndrome in remission.
    Ragnarsson O; Stomby A; Dahlqvist P; Evang JA; Ryberg M; Olsson T; Bollerslev J; Nyberg L; Johannsson G
    Psychoneuroendocrinology; 2017 Aug; 82():117-125. PubMed ID: 28544904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morbidity of Cushing's Syndrome and Impact of Treatment.
    Webb SM; Valassi E
    Endocrinol Metab Clin North Am; 2018 Jun; 47(2):299-311. PubMed ID: 29754633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study of psychiatric and psychological aspects of Cushing's syndrome.
    Kelly WF; Kelly MJ; Faragher B
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):715-20. PubMed ID: 9039337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cushing's Syndrome and Psychosis: A Case Report and Literature Review.
    Fujii Y; Mizoguchi Y; Masuoka J; Matsuda Y; Abe T; Anzai K; Kunitake Y; Tateishi H; Inaba T; Murakawa T; Kato TA; Monji A
    Prim Care Companion CNS Disord; 2018 Sep; 20(5):. PubMed ID: 30256544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies.
    Andela CD; van Haalen FM; Ragnarsson O; Papakokkinou E; Johannsson G; Santos A; Webb SM; Biermasz NR; van der Wee NJ; Pereira AM
    Eur J Endocrinol; 2015 Jul; 173(1):R1-14. PubMed ID: 25650405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Executive functioning in unipolar depression: a review].
    Fossati P; Ergis AM; Allilaire JF
    Encephale; 2002; 28(2):97-107. PubMed ID: 11972136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol.
    Jeffcoate WJ; Silverstone JT; Edwards CR; Besser GM
    Q J Med; 1979 Jul; 48(191):465-72. PubMed ID: 542586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired decision-making and selective cortical frontal thinning in Cushing's syndrome.
    Crespo I; Esther GM; Santos A; Valassi E; Yolanda VG; De Juan-Delago M; Webb SM; Gómez-Ansón B; Resmini E
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):826-33. PubMed ID: 25052342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric aspects of Cushing's syndrome.
    Kelly WF
    QJM; 1996 Jul; 89(7):543-51. PubMed ID: 8759496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subtle cognitive impairments in patients with long-term cure of Cushing's disease.
    Tiemensma J; Kokshoorn NE; Biermasz NR; Keijser BJ; Wassenaar MJ; Middelkoop HA; Pereira AM; Romijn JA
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2699-714. PubMed ID: 20371667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated resting-state connectivity in the medial temporal lobe and the prefrontal cortex among patients with Cushing's syndrome in remission.
    Stomby A; Salami A; Dahlqvist P; Evang JA; Ryberg M; Bollerslev J; Olsson T; Johannsson G; Ragnarsson O
    Eur J Endocrinol; 2019 May; 180(5):329-338. PubMed ID: 30939453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive function in patients with Cushing syndrome: a longitudinal perspective.
    Dorn LD; Cerrone P
    Clin Nurs Res; 2000 Nov; 9(4):420-40. PubMed ID: 11881698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common genetic variants in the glucocorticoid receptor and the 11β-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing's syndrome in remission.
    Ragnarsson O; Glad CA; Berglund P; Bergthorsdottir R; Eder DN; Johannsson G
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1803-7. PubMed ID: 24915124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of Life in Cushing's disease: A long term issue?
    Webb SM; Santos A; Resmini E; Martínez-Momblán MA; Martel L; Valassi E
    Ann Endocrinol (Paris); 2018 Jun; 79(3):132-137. PubMed ID: 29625700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment.
    Sonino N; Fava GA
    CNS Drugs; 2001; 15(5):361-73. PubMed ID: 11475942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.